NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday

NovaBay Pharmaceuticals (NYSEAMERICAN:NBYGet Free Report) will likely be releasing its earnings data before the market opens on Tuesday, March 25th. Analysts expect NovaBay Pharmaceuticals to post earnings of ($0.19) per share and revenue of $2.50 million for the quarter.

NovaBay Pharmaceuticals Stock Performance

NovaBay Pharmaceuticals stock opened at $0.64 on Tuesday. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $9.08. The stock has a market capitalization of $2.71 million, a PE ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

(Get Free Report)

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.

See Also

Earnings History for NovaBay Pharmaceuticals (NYSEAMERICAN:NBY)

Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.